Basic Information
ImmunoMet Therapeutics, founded in July 2015, is a biotech startup at the research and development stage, dedicated to utilizing cellular metabolism to develop novel anti-cancer drugs and cancer immunotherapies.
Enterprise Profile
Technology
Concept